US OPEN: Bulls return to Wall Street; US100 gains 3.2% 📈

4:38 pm 23 April 2025

US markets are opening Wednesday's cash session in very good spirits. Five minutes after Wall Street opened, the Nasdaq is up 3.2%, while the S&P500 is up 2.65%. Markets reacted to President Donald Trump's statement that he has no intention of firing Federal Reserve Chairman Jerome Powell and indicated that he would cut tariffs on China if an agreement could be reached.

Current volatility observed on Wall Street. Source: xStation

US100

The Nasdaq-100 index, represented by the US100 contract, is trading 3.2% higher today compared to yesterday's close. The index continues to maintain a dynamic downtrend as long as the supply side is able to sustainably hold below the 200-day EMA (golden curve) and local highs from April 10.

Source: xStation 5

News

The general recovery on Wall Street is particularly beneficial to Mag7 companies. Tesla (TSLA.US) shares are doing very well, adding almost 7% after Elon Musk announced his resignation from government duties. Other companies are also recording significant increases: Alphabet (GOOGL.US) +2.4%, Nvidia (NVDA.US) +5.4%, Amazon (AMZN.US) +4%, Apple (AAPL.US), +3.3%, Microsoft (MSFT.IS) +2.6%, Meta (META.US) +4.9%.

On the other hand, Apple has been fined €500 million and Meta €200 million as EU antitrust regulators imposed the first sanctions under groundbreaking legislation aimed at curbing Big Tech’s power in Europe.

The semiconductor sector, cryptocurrency-linked stocks and US-listed Chinese companies are all rising after Trump said tariffs on China would be cut if the two countries reached an agreement. The president also said he had no intention of firing Powell.

  • Semiconductors: SMCI (SMCI) +7%, Nvidia (NVDA) +5.4%, Dell (DELL) +5.4%
  • Apple suppliers: Qualcomm (QCOM) +2.4%, Broadcom (AVGO) +4.9%
  • Cryptocurrency-linked stocks: Robinhood (HOOD) +8.4%, Coinbase (COIN) +4.2%, MicroStrategy (MSTR) +3.4%
  • China ADRs: Alibaba (BABA) +3%, PDD (PDD) +4%

AT&T (T) is up 2% after adding 324,000 mobile phone customers in the first quarter, beating Wall Street’s estimate of 254,000. Here are the company’s other results:

- Adjusted earnings per share: $0.51 (est. $0.52)

- Revenue: $30.6 billion (est. $30.38 billion)

- Adjusted earnings before interest, taxes, depreciation, and amortization (est. $11.33 billion)

Other news:

  • Boston Scientific (BSX.US) is up 8% after the medical device company raised its full-year net sales and adjusted earnings forecasts.
  • Bristol-Myers Squibb (BMY.US) is down 3% after the company’s schizophrenia treatment failed.
  • Intel Corp. (INTC.US) is up 5% as the company is poised to announce plans this week to lay off more than 20% of its staff.
  • Novavax (NVAX.US) is up 12% after the company said its biologics license application for a COVID-19 vaccine remains approved based on discussions with the FDA.

 

 

The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.

Share:
Back

Join over 1 600 000 XTB Group Clients from around the world.